Cita APA

Kummar, S., Shen, L., Hong, D. S., McDermott, R., Keedy, V., Casanova, M., & Gallego, S. (2023). Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.

Citación estilo Chicago

Kummar, Shivaani, Lin Shen, David S. Hong, Ray McDermott, Vicki Keedy, Michela Casanova, y Soledad Gallego. Larotrectinib Efficacy and Safety in Adult Patients With Tropomyosin Receptor Kinase Fusion Sarcomas. 2023.

Cita MLA

Kummar, Shivaani, et al. Larotrectinib Efficacy and Safety in Adult Patients With Tropomyosin Receptor Kinase Fusion Sarcomas. 2023.